The leading bioeconomy blog Il Bioeconomista has published an interview with GFBiochemicals’ Chief Commercial Officer. Marcel van Berkel talks about the future of biomaterials and levulinic acid as a biobased building block.
Marcel said, “Rather than wait and see, we prefer to be pioneers of the emerging bioeconomy bringing biobased solutions like levulinic acid and its derivatives to the market. Another major driver for the development of levulinic acid is the clear performance advantages and the cost profile GFBiochemicals offers.”
Read the full article here.